Roberto Lorbeer

Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes

Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study

Long COVID: major findings, mechanisms and recommendations

Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin

Hepatocellular carcinoma

Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension

Mechanisms of NAFLD development and therapeutic strategies

Non-alcoholic fatty liver disease

Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

Therapeutic targeting of the angiopoietin–TIE pathway

The utility of radiological imaging in nonalcoholic fatty liver disease

VEGF in Signaling and Disease: Beyond Discovery and Development

NAFLD: A multisystem disease

Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease

Mitral Annulus Calcification

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Nonalcoholic Fatty Liver Disease

NAFLD and Chronic Kidney Disease

Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study

Aortic and Mitral Annular Calcifications Are Predictive of All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes

Hepatic Steatosis Is Associated With Aortic Valve Sclerosis in the General Population

Circulating Angiopoietin-2, Its Soluble Receptor Tie-2, and Mortality in the General Population

Heart valve sclerosis predicts all-cause and cardiovascular mortality

Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease

The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study

Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease